These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24516924)

  • 1. [Strengthen researches on risk factors and early diagnosis of nonalcoholic fatty liver].
    Li YM
    Zhonghua Gan Zang Bing Za Zhi; 2013 Nov; 21(11):805-7. PubMed ID: 24516924
    [No Abstract]   [Full Text] [Related]  

  • 2. Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China).
    Fan JG; Wei L; Zhuang H;
    J Dig Dis; 2019 Apr; 20(4):163-173. PubMed ID: 30444584
    [No Abstract]   [Full Text] [Related]  

  • 3. [Liver diseases. Non-alcoholic fatty liver disease].
    Bernal Reyes R
    Rev Gastroenterol Mex; 2010 Aug; 75 Suppl 1():181-3. PubMed ID: 20959244
    [No Abstract]   [Full Text] [Related]  

  • 4. Foreword. Nonalcoholic Fatty Liver Disease.
    Day CP; Anstee QM
    Semin Liver Dis; 2015 Aug; 35(3):203-6. PubMed ID: 26378638
    [No Abstract]   [Full Text] [Related]  

  • 5. [Current Status and Future Prospects of Nonalcoholic Fatty Liver Disease (NAFLD) in Japan-Feedback from Clinical and Basic Researches to Medical Therapy and Pharmacist Activities].
    Tokuyama S; Kim KI
    Yakugaku Zasshi; 2016; 136(4):563. PubMed ID: 27040339
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter to the editor: Treating nonalcoholic fatty liver disease with statins. Are all statins equal?
    Athyros VG; Katsiki N; Mikhailidis DP
    Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G681-G682. PubMed ID: 28596414
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevalence of nonalcoholic fatty liver disease in Asia].
    Zhang W; Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2013 Nov; 21(11):801-4. PubMed ID: 24516923
    [No Abstract]   [Full Text] [Related]  

  • 8. Nonalcoholic Fatty Liver Disease and the Need for Action.
    Sporea I; Sirli R
    J Gastrointestin Liver Dis; 2020 Jun; 29(2):139-141. PubMed ID: 32530977
    [No Abstract]   [Full Text] [Related]  

  • 9. Commonalities and Distinctions Between Alcoholic and Nonalcoholic Fatty Liver Disease.
    Sanyal AJ; Mathurin P; Nagy LA
    Gastroenterology; 2016 Jun; 150(8):1695-7. PubMed ID: 27155520
    [No Abstract]   [Full Text] [Related]  

  • 10. [Progress in the study of nonalcoholic fatty liver disease: insights from research in 2013].
    Shen F; Fan J
    Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):178-80. PubMed ID: 24919224
    [No Abstract]   [Full Text] [Related]  

  • 11. How Safe Is Moderate Alcohol Consumption in Overweight and Obese Individuals?
    Sookoian S; Pirola CJ
    Gastroenterology; 2016 Jun; 150(8):1698-1703.e2. PubMed ID: 26775630
    [No Abstract]   [Full Text] [Related]  

  • 12. [[Current approaches to diagnosing and treating nonalcoholic fatty liver disease].
    Drapkina OM; Deeva TA; Volkova NP; Ivashkin VT
    Ter Arkh; 2014; 86(10):116-23. PubMed ID: 25509904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic Fatty Liver Disease: Epidemiology, Natural History, and Diagnostic Challenges.
    Cholankeril G; Perumpail RB; Pham EA; Ahmed A; Harrison SA
    Hepatology; 2016 Sep; 64(3):954. PubMed ID: 27388553
    [No Abstract]   [Full Text] [Related]  

  • 14. [Relationship between normal serum uric acid levels and nonalcoholic fatty liver disease in postmenopausal women].
    Liu P; Ma F; Lou H; Zhu Y; Chen Y
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jan; 22(1):53-7. PubMed ID: 24721245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty liver: yet another silent killer.
    Javed M
    J Ayub Med Coll Abbottabad; 2014; 26(1):1-2. PubMed ID: 25358204
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prospective cohort study of the predictive value of hemoglobin levels for non-alcoholic fatty liver disease].
    Cai W; Zhang B; Miao L; Wang T; Zou Y; Li Y; Yao H
    Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):200-4. PubMed ID: 24824122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    ; LaBrecque DR; Abbas Z; Anania F; Ferenci P; Khan AG; Goh KL; Hamid SS; Isakov V; Lizarzabal M; Peñaranda MM; Ramos JF; Sarin S; Stimac D; Thomson AB; Umar M; Krabshuis J; LeMair A;
    J Clin Gastroenterol; 2014 Jul; 48(6):467-73. PubMed ID: 24921212
    [No Abstract]   [Full Text] [Related]  

  • 18. [Nonalcoholic fatty liver disease. Pathophysiologically oriented diagnosis and therapy].
    Ströhle A; Stein J
    Med Monatsschr Pharm; 2015 May; 38(5):166-78; quiz 179-80. PubMed ID: 26364406
    [No Abstract]   [Full Text] [Related]  

  • 19. [S2k Guideline non-alcoholic fatty liver disease].
    Roeb E; Steffen HM; Bantel H; Baumann U; Canbay A; Demir M; Drebber U; Geier A; Hampe J; Hellerbrand C; Pathil-Warth A; Schattenberg JM; Schramm C; Seitz HK; Stefan N; Tacke F; Tannapfel A; Lynen Jansen P; Bojunga J
    Z Gastroenterol; 2015 Jul; 53(7):668-723. PubMed ID: 26167698
    [No Abstract]   [Full Text] [Related]  

  • 20. Nonalcoholic Fatty Liver Disease: An Expanding Health Care Epidemic.
    Bernstein DE
    Clin Liver Dis; 2018 Feb; 22(1):xiii-xiv. PubMed ID: 29128064
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.